Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

(2021) David S. Khoury et al.   NATURE MEDICINE

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

(2021) P. Grivas et al.   ANNALS OF ONCOLOGY

Seroconversion rates following COVID-19 vaccination among patients with cancer

(2021) Astha Thakkar et al.   CANCER CELL

Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer

(2021) Sidse Ehmsen et al.   CANCER CELL

Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study

(2021) Julia Hippisley-Cox et al.   BMJ-British Medical Journal

mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial

(2021) Sjoukje F Oosting et al.   LANCET ONCOLOGY

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

(2020) Nicole M Kuderer et al.   LANCET